- Home
- BCRX vs GENI Comparison
BCRX vs GENI Comparison
Compare BCRX & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- GENI
- Stock Information
- Founded
- BCRX 1986
- GENI 2016
- Country
- BCRX United States
- GENI United Kingdom
- Employees
- BCRX N/A
- GENI N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- GENI Services-Misc. Amusement & Recreation
- Sector
- BCRX Health Care
- GENI Consumer Discretionary
- Exchange
- BCRX Nasdaq
- GENI Nasdaq
- Market Cap
- BCRX 1.6B
- GENI 1.5B
- IPO Year
- BCRX 1994
- GENI N/A
- Fundamental
- Price
- BCRX $7.95
- GENI $7.55
- Analyst Decision
- BCRX Buy
- GENI Strong Buy
- Analyst Count
- BCRX 6
- GENI 9
- Target Price
- BCRX $14.17
- GENI $9.50
- AVG Volume (30 Days)
- BCRX 1.7M
- GENI 2.6M
- Earning Date
- BCRX 10-31-2024
- GENI 08-06-2024
- Dividend Yield
- BCRX N/A
- GENI N/A
- EPS Growth
- BCRX N/A
- GENI N/A
- EPS
- BCRX N/A
- GENI N/A
- Revenue
- BCRX $382,236,000.00
- GENI $444,066,000.00
- Revenue This Year
- BCRX $33.34
- GENI $25.92
- Revenue Next Year
- BCRX $17.44
- GENI $14.24
- P/E Ratio
- BCRX N/A
- GENI N/A
- Revenue Growth
- BCRX 24.65
- GENI 20.65
- 52 Week Low
- BCRX $4.03
- GENI $4.62
- 52 Week High
- BCRX $8.88
- GENI $8.15
- Technical
- Relative Strength Index (RSI)
- BCRX 51.57
- GENI 55.46
- Support Level
- BCRX $7.98
- GENI $7.26
- Resistance Level
- BCRX $8.88
- GENI $7.75
- Average True Range (ATR)
- BCRX 0.32
- GENI 0.31
- MACD
- BCRX -0.08
- GENI -0.03
- Stochastic Oscillator
- BCRX 29.32
- GENI 62.29
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.